First-in-human, dose-escalation, phase (ph) I trial to evaluate safety of anti-Axl antibody-drug conjugate (ADC) enapotamab vedotin (EnaV) in solid tumors
Ameratunga, Malaka, Harvey, R Donald, Mau-Sørensen, Morten, Thistlethwaite, Fiona, Forssmann, Ulf, Gupta, Manish, Johannsdottir, Hrefna, Ramirez-Andersen, Terrie, Bohlbro, Mika Linette, Losic, Nedjad, Ervin-Haynes, Annette L., Lopez, Juanita Suzanne, Vergote, Ignace
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article